Lack of Regulatory Changes of μ-Opioid Receptors by 14-Methoxymetopon Treatment in Rat Brain. Further Evidence for Functional Selectivity

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|42|7348-7354

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.42, 2013-12, pp. : 7348-7354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

14-methoxymetopon, a highly potent μ opioid agonist, biphasically affects ethanol intake in Sardinian alcohol-preferring rats

By Sabino Valentina   Cottone Pietro   Steardo Luca   Schmidhammer Helmut   Zorrilla Eric  

Psychopharmacology, Vol. 192, Iss. 4, 2007-07 ,pp. : 537-546

Springer Publishing Company

Access to resources Recommend Favorite

Functional interactions between - and -opioid receptors in rat thermoregulation

By Salmi P.   Kela J.   Arvidsson U.   Wahlestedt C.  

European Journal of Pharmacology, Vol. 458, Iss. 1, 2003-01 ,pp. : 101-106

Elsevier

Access to resources Recommend Favorite

14-Methoxymetopon, a very potent -opioid receptor-selective analgesic with an unusual pharmacological profile

By King M.A.   Su W.   Nielan C.L.   Chang A.H.   Schutz J.   Schmidhammer H.   Pasternak G.W.  

European Journal of Pharmacology, Vol. 459, Iss. 2, 2003-01 ,pp. : 203-209

Elsevier

Access to resources Recommend Favorite

Commentary [Targeting Opioid Receptors: A New Treatment for Brain Disorders]

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-04 ,pp. : 128-128

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of humoral immune responses in the rat by centrally applied Met-Enk and opioid receptor antagonists: functional interactions of brain OP 1 , OP 2 and OP 3 receptors

By Dimitrijevic M.   Stanojevic S.   Kovacevic-Jovanovic V.   Miletic T.   Vujic-Redzic V.   Radulovic J.  

Immunopharmacology, Vol. 49, Iss. 3, 2000-09 ,pp. : 255-262

Elsevier

Access to resources Recommend Favorite